Transaction in Own Shares

SECISSUE
Wed, Oct 22 2025 08:30 am

Stock Exchange Announcement
Templeton Emerging Markets Investment Trust PLC ("the Company")
Transaction in Own Shares
Legal Entity Identifier 5493002NMTB70RZBXO96


The Company announces that, on 21 October 2025, it purchased for cancellation 358,000 Ordinary shares of 5 pence each in the Company ("Shares") at a price of 226.86 pence per Share.

Following this transaction, the Company's share capital consists of 969,454,508 Shares in issue and 60,000,000 Shares held in Treasury. Therefore, the total number of voting rights in the Company is 969,454,508. In order to protect the interests of existing shareholders, shares held in treasury will only be reissued at a price above the prevailing NAV per share at the time of reissue.

This figure (969,454,508) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please e-mail [email protected].


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.


Announcement PDF


Markets News

NZ sharemarket edges higher as F&P Healthcare weighs on gains
Markets Market Close

NZ sharemarket edges higher as F&P Healthcare weighs on gains

The S&P/NZX 50 Index closed 14.49 points or 0.11% down at 13,391.59.

Finance

Kiwibank wary of capital-review barrier to growth

Kiwibank raises issues of competitive advantage.

Kiwibank wary of capital-review barrier to growth
Primary Sector

Fonterra windfall brings risks: ASB

Farmers will vote for the Lactalis deal on Oct 30.

Fonterra windfall brings risks: ASB